Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Haemonetics Corp HAE

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma... see more

Recent & Breaking News (NYSE:HAE)

Haemonetics Receives FDA Clearance For NexSys PCS® With Persona(TM) Technology

PR Newswire October 2, 2020

Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference

PR Newswire September 9, 2020

Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting

PR Newswire August 7, 2020

Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website

PR Newswire August 4, 2020

Haemonetics Announces Sale Of Inlog Holdings France SAS To Abénex Capital

PR Newswire July 24, 2020

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2021 Results: August 4, 2020

PR Newswire July 6, 2020

Haemonetics Announces 2020 Annual Meeting Of Shareholders Will Be Conducted In Virtual Format

PR Newswire June 30, 2020

Haemonetics Announces Blood Filter Supply Agreement And Sale Of Puerto Rico-Based Manufacturing Operations To GVS, S.p.A

PR Newswire June 3, 2020

Haemonetics Announces Sale Of U.S. Blood Donor Management Software Solution Assets To The GPI Group

PR Newswire May 28, 2020

Haemonetics 4th Quarter and Fiscal 2020 Earnings Release Available on Investor Relations Website

PR Newswire May 5, 2020

Michael Coyle Joins Haemonetics Board of Directors

PR Newswire April 17, 2020

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2020 Results: May 5, 2020

PR Newswire April 3, 2020

Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio

PR Newswire April 2, 2020

Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer

PR Newswire March 30, 2020

Haemonetics 3rd Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website

PR Newswire February 4, 2020

Haemonetics Announces Acquisition Of Intellectual Property Assets Relating To TEG® 6s Hemostasis Analyzer System

PR Newswire January 14, 2020

T2 Biosystems Promotes Tony Pare to Chief Commercial Officer

GlobeNewswire January 13, 2020

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2020 Results: February 4, 2020

PR Newswire December 19, 2019

Haemonetics Opens New Corporate Headquarters In Downtown Boston

PR Newswire December 11, 2019

Haemonetics Releases Next Generation SafeTrace Tx® Transfusion Management Software in North America

PR Newswire December 3, 2019